Kimberly A. Skelding M.D., FSCAI, FACC, FAHA

Associate, Interventional Cardiology
Geisinger Medical Center
Director of Cardiovascular Genomics and Cardiovascular Research 
Geisinger Center for Health Research
Danville, Pennsylvania

Dr. Skelding is currently an Associate in Interventional Cardiology and serves as the Director of Cardiovascular Genomics and Cardiovascular Research at the Geisinger Center for Health Research at Geisinger Medical Center in Danville, PA.  Prior to her current position, she was an Assistant Professor of Medicine, completing an advanced cardiovascular and interventional fellowship at the Mayo Clinic in Rochester, MN, after completing a cardiology fellowship at William Beaumont Hospital in Royal Oak, MI.

Dr. Skelding actively serves on committees of the Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology, and American Heart Association. She has been active with local and national mentorship initiatives and is currently the co-chair of the Career Development Committee of SCAI.  She also leads the local Women’s Cardiovascular Initiative to identify areas for improvement in the treatment of cardiovascular disease in women.

Dr. Skelding’s research interests are percutaneous coronary intervention outcomes, the treatment of myocardial infarction, and genetic effects on interventional outcomes. She directs the Genomics Initiative for the Dynamic Registry Wave 5; is principal investigator of the CardioGene Trial in collaboration with the National Heart, Lung and Blood Institute, which studies the genomics of in-stent restenosis; and has received peer-reviewed funding in this area. She is local principal investigator on numerous large clinical trials and has an active interventional practice in coronary and structural heart disease.

Dr. Skelding is the Editor of Seconds-Count's section titled, "What's New?"